Table 3.
Incubation of MCF-10F cells with 4-OHE2 alone or in the presence of NAcCys1
| 4-OHE2 alone | 4-OHE2: NAcCys (1:0.5) | 4-OHE2: NAcCys (1:1) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected Compounds2 | 1 | 10 | 30 | 1 | 10 | 30 | 1 | 10 | 30 |
| pmol/10 million cells | |||||||||
| 4-OHE1(E2) | 2.20 ± 0.45 |
9.49 ± 2.04 |
29.5 ± 3.45 |
1.11 ± 0.33 |
5.47 ± 0.71 |
14.2 ± 2.17 |
0.27 ± 0.07 |
2.42 ± 0.45 |
7.37 ± 1.4 |
| 4-OCH3E1(E2) | 1139 ± 106 |
3788 ± 353 |
10648 ± 1211 |
1282 ± 124 |
4500* ± 259 |
14944* ± 1316 |
1461* ± 200 |
5598* ± 500 |
23736* ± 1467 |
| 4-OHE1(E2)-2-SG | 1.10 ± 0.21 |
7.48 ± 0.77 |
12.2 ± 3.34 |
1.19 ± 0.16 |
8.57 ± 0.57 |
14.4 ± 2.09 |
1.32* ± 0.15 |
9.87 ± 2.19 |
17.3 ± 2.94 |
| 4-OHE1(E2)-2-Cys | 5.16 ± 0.55 |
9.98 ± 0.24 |
37.3 ± 1.26 |
5.74 ± 0.53 |
11.7* ± 0.72 |
46.2* ± 4.29 |
6.76* ± 1.08 |
14.2* ± 2.29 |
58.6* ± 3.30 |
| 4-OHE1(E2)-2-NAcCys | 5.0 ± 0.65 |
11.5 ± 2.0 |
31.0 ± 3.86 |
5.57 ± 1.10 |
13.2 ± 2.26 |
38.6* ± 3.95 |
6.84* ± 0.60 |
16.6* ± 3.31 |
51.2* ± 3.63 |
| 4-OHE1(E2)-1-N3Ade | 0.84 ± 0.09 |
3.76 ± 0.53 |
11.2 ± 2.38 |
0.68* ± 0.07 |
2.63* ± 0.20 |
6.07* ± 2.20 |
0.53* ± 0.03 |
1.14* ± 0.19 |
1.57* ± 0.34 |
| 4-OHE1(E2)-1-N7Gua | 0.70 ± 0.19 |
2.86 ± 0.28 |
9.99 ± 1.20 |
0.59 ± 0.05 |
2.11* ± 0.28 |
6.26* ± 1.24 |
0.51* ± 0.04 |
1.05* ± 0.08 |
1.52* ± 0.29 |
MCF-10F cells were incubated at 37 °C for 24 h with 4-OHE2 (1, 10 or 30 µM) alone or in the presence of different ratios of NAcCys.
The compounds were identified and quantified by HPLC-ECD and the adducts were confirmed by UPLC-MS/MS; values are an average of three replicates from three independent pools of medium each from a set of five flasks; ± standard deviation.
The value is significantly different from th at in the cells not treated with NAcCys (p<0.05) as determined by the t-test.